Zobrazeno 1 - 1
of 1
pro vyhledávání: '"S Moranha Fernandez"'
Autor:
E Tarazon Melguizo, S. Rodriguez Segade, L Anido Varela, Oreste Gualillo, M. Portoles, J Rodriguez Garcia, J R Gonzalez Juanatey, F Lago Paz, S Moranha Fernandez, M. Otero Santiago, E. Rosello Lleti, Sandra Feijóo-Bandín, T Garcia Caballero, A. Aragon Herrera
Publikováno v:
European Heart Journal. 41
Background Empagliflozin is a potent, highly selective sodium glucose cotransporter-2 (SGLT2) inhibitor used as an effective and well-tolerated antihyperglycaemic agent. Beyond lowering glucose, empagliflozin exerts a favorable effect on a number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa5d374090e54a3a021ba7277fe51067
https://doi.org/10.1093/ehjci/ehaa946.3825
https://doi.org/10.1093/ehjci/ehaa946.3825
